Skip to main content

ADVERTISEMENT

cost-effectiveness

Research Reports
10/20/2021
Poorni M. Manohar, MD, et al assessed the potential value of 18-F 16 alpha-fluoroestradiol positron emission tomography (FES-PET) vs biopsy to determine estrogen receptor status and guide therapy selection in metastatic breast cancer.
Poorni M. Manohar, MD, et al assessed the potential value of 18-F 16 alpha-fluoroestradiol positron emission tomography (FES-PET) vs biopsy to determine estrogen receptor status and guide therapy selection in metastatic breast cancer.
Poorni M. Manohar, MD, et al...
10/20/2021
Journal of Clinical Pathways
Department
04/12/2017
JCP Editors
Recent research suggests a particular immunotherapy may be less costly and offer time savings compared with nivolumab for patients with metastatic non-small cell lung cancer (NSCLC). Immune checkpoint inhibitors,...
Recent research suggests a particular immunotherapy may be less costly and offer time savings compared with nivolumab for patients with metastatic non-small cell lung cancer (NSCLC). Immune checkpoint inhibitors,...
Recent...
04/12/2017
Journal of Clinical Pathways
Research in Review
11/15/2016
JCP Editors
Targeted therapies have been shown to significantly improve the survival of patients with human epidermal growth factor 2 (HER2)-positive metastatic breast cancer. However, these therapies have also been associated...
Targeted therapies have been shown to significantly improve the survival of patients with human epidermal growth factor 2 (HER2)-positive metastatic breast cancer. However, these therapies have also been associated...
...
11/15/2016
Journal of Clinical Pathways
12/11/2014
Use of Negative Pressure Wound Therapy With Automated, Volumetric Instillation for the Treatment of Extremity and Trunk Wounds: Clinical Outcomes and Potential Cost-Effectiveness Allen Gabriel, MD,a Kevin Kahn, MD,b and Riyad...
Use of Negative Pressure Wound Therapy With Automated, Volumetric Instillation for the Treatment of Extremity and Trunk Wounds: Clinical Outcomes and Potential Cost-Effectiveness Allen Gabriel, MD,a Kevin Kahn, MD,b and Riyad...
Use of Negative Pressure...
12/11/2014
ePlasty